Blog Network

Upcoming Events

About

The Future of BioPharma blog provides timely coverage of news that directly impacts the business strategies of the biotech, pharmaceutical and medical device industries. In addition to news coverage, the Future of BioPharma blog features live event coverage from IIR's Biopharmaceutical and Healthcare division.

Blog Archive

Favorites

Tuesday, April 30, 2013

The flu vaccine has become a staple in the United States - The Bolus cites several reasons including expanded access and improved awareness and education. But there is currently a small portion of potential individuals who can't revive the current flu vaccine - those who are allergic to eggs. However, recently the FDA has approved two types of egg-free vaccines including Flucelvex and Flublok for adults over the age of 18. These two procedures have found alternative ways that can leave chicken embryo fluid out of the vaccine development process.

This coming June at the Vaccines Development and Production Event, Manon M.J. Cox, President and CEO, Protein Sciences Corporation, will be on hand to discuss the development of Flublok®. For more information on Manon's presentation, download the agenda. If you'd like to join us June 3-5 in Durham, North Carolina, as a reader of this blog when you register to join us and mention code VDPS13JP, you'll save 20% off the standard rate!

Share this article with your social network, just click below to share now!